TGFB1 and hepatoblastoma: We further examined whether ATD affected TGF-β1-promoted invasion in HepG2 hepatoblastoma cells using the transwell assay, and the results show that treatment with ATD (25 μM and 50 μM) significantly inhibited TGF-β1-promoted cell invasion (Figure 4).